Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromhexine Hydrochloride for Mild COVID-19
NCT04273763Phase 2Unknown
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Feb 2020
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bromhexine in coronavirus disease 2019 (COVID-19), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Status: unknown.
02
Drugs
bromhexine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04273763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04273763.